SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001144204-15-073635
Filing Date
2015-12-31
Accepted
2015-12-31 16:32:34
Documents
13

Document Format Files

Seq Description Document Type Size
1 FORM F-1 v427869_f1.htm F-1 2473278
2 EXHIBIT 10.3 v427869_ex10-3.htm EX-10.3 97265
3 EXHIBIT 10.8 v427869_ex10-8.htm EX-10.8 18500
4 EXHIBIT 10.9 v427869_ex10-9.htm EX-10.9 73271
5 EXHIBIT 10.10 v427869_ex10-10.htm EX-10.10 65236
6 EXHIBIT 10.11 v427869_ex10-11.htm EX-10.11 82919
7 EXHIBIT 21.1 v427869_ex21-1.htm EX-21.1 3409
8 EXHIBIT 23.1 v427869_ex23-1.htm EX-23.1 7710
9 GRAPHIC tlogo1.jpg GRAPHIC 22706
10 GRAPHIC tpg40.jpg GRAPHIC 86120
11 GRAPHIC tlogo.jpg GRAPHIC 4349
12 GRAPHIC image_001.jpg GRAPHIC 2317
13 GRAPHIC image_002.jpg GRAPHIC 2317
  Complete submission text file 0001144204-15-073635.txt   2985471
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
Type: F-1 | Act: 33 | File No.: 333-208817 | Film No.: 151316124
SIC: 2834 Pharmaceutical Preparations